LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $2.6M of Standard BioTools Inc.
Director and 10% owner
Bought$2,559,641
$1.62Price
1,575,408Shares
+2%Stake
What LAB did for a copier
- $1,000 copied at Wed, Aug 14 open, $1.67
- $1,138
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Sep 26 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −10.6% against the S&P 500, and 6 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 9. Filed Tue, Aug 13, 4:15 PM ET, after the close. Returns use the Aug 14 open and the Sep 26 close. Not investment advice.